No More Easy Vaccines, Merck's Gerberding Says In Call For Collaboration
This article was originally published in The Pink Sheet Daily
Executive Summary
The easy ones have already been created, she tells BIO, noting there is growing cooperation in pre-competitive activities.
You may also be interested in...
FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg
FDA is considering further “modulations” of its current approaches to drug approvals in order to encourage innovation and get products to market more quickly, Commissioner Margaret Hamburg commented during a panel session at the Biotechnology Industry Organization International Convention in Washington, D.C. on June 28.
FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg
FDA is considering further “modulations” of its current approaches to drug approvals in order to encourage innovation and get products to market more quickly, Commissioner Margaret Hamburg commented during a panel session at the Biotechnology Industry Organization International Convention in Washington, D.C. on June 28.
Selecta/JDRF Collaboration Seeks Vaccine To Prevent Or Treat Type 1 Diabetes
JDRF will provide milestone-based financial support toward preclinical proof of concept for a tolerogenic vaccine candidate.